Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 2201–2220 of 17,529 recalls

April 26, 2023· Akorn, Inc.

Recalled Item: Lidocaine Hydrochloride Oral Topical Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Lidocaine HCl Jelly USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Levetiracetam Oral Solution 100 mg/mL (100 mg/mL)

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Cetrorelix Acetate for Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: HydrALAZINE HCl Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Guaiatussin AC Sugar-Free

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Hydrocortisone and Acetic Acid Otic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Sulfamethoxazole & Trimethoprim Oral Suspension USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Lorazepam Oral Concentrate

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Lactulose Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Cimetidine HCl Oral Solution 300mg/5mL

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Hydromorphone Hydrochloride Injection

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: XOPENEX (levalbuterol HCl) Inhalation Solution Concentrate

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Pilocarpine Hydrochloride Ophthalmic Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Vitamin D Supplement Drops

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Rifampin Capsules USP

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Sodium DIURIL (chlorothiazide sodium)

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 26, 2023· Akorn, Inc.

Recalled Item: Promethazine HCl & Codeine Phosphate Oral Solution

The Issue: CGMP Deviations: Firm went out of business and

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund